CAPRICOR THERAPEUTICS, INC. (CAPR) Capital expenditures 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.9MFY2025 · since FY2016: $191,970 → $2.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.9M | +148.9% |
| FY2024 | $1.2M | -11.0% |
| FY2023 | $1.3M | -34.4% |
| FY2022 | $2.0M | +67.2% |
| FY2021 | $1.2M | +118.5% |
| FY2020 | $547,601 | — |
| FY2019 | $0 | -100.0% |
| FY2018 | $316,486 | +883.3% |
| FY2017 | $32,185 | -83.2% |
| FY2016 | $191,970 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice